Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19

Dan H. Barouch, View ORCID ProfileKathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
doi: https://doi.org/10.1101/2021.07.05.21259918
Dan H. Barouch
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dbarouch@bidmc.harvard.edu
Kathryn E. Stephenson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn E. Stephenson
Jerald Sadoff
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingyou Yu
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aiquan Chang
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makda Gebre
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine McMahan
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinyan Liu
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abishek Chandrashekar
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivani Patel
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Le Gars
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Marit de Groot
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Heerwegh
3Janssen Research & Development, Beerse, Belgium
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Struyf
3Janssen Research & Development, Beerse, Belgium
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Macaya Douoguih
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan van Hoof
2Janssen Vaccines & Prevention, Leiden, The Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanneke Schuitemaker
2Janssen Vaccines & Prevention, Leiden, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Interim immunogenicity and efficacy data for the Ad26.COV2.S vaccine for COVID-19 have recently been reported1-3. We describe here the 8-month durability of humoral and cellular immune responses in 20 individuals who received one or two doses of 5×1010 vp or 1011 vp Ad26.COV2.S and in 5 participants who received placebo2. We evaluated antibody and T cell responses on day 239, which was 8 months after the single-shot vaccine regimen (N=10) or 6 months after the two-shot vaccine regimen (N=10), although the present study was not powered to compare these regimens3. We also report neutralizing antibody responses against the parental SARS-CoV-2 WA1/2020 strain as well as against the SARS-CoV-2 variants D614G, B.1.1.7 (alpha), B.1.617.1 (kappa), B.1.617.2 (delta), P.1 (gamma), B.1.429 (epsilon), and B.1.351 (beta).

Competing Interest Statement

D.H.B. is a co-inventor on related vaccine patents. J.S., M.L.G., A.M.G., D.H., F.S., M.D., J.V.H., and H.S. are employees of Janssen Pharmaceuticals and may be co-inventors on related vaccine patents.

Clinical Trial

NCT04436276

Funding Statement

We acknowledge support from Janssen Vaccines & Prevention BV, the Ragon Institute of MGH, MIT, the Massachusetts Consortium on Pathogen Readiness (MassCPR), the Musk Foundation, the National Institutes of Health (CA260476). This project has been funded in part with federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Other Transaction Agreement HHSO100201700018C.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

BIDMC IRB

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Requests for access to the study data can be submitted to D.H.B. (dbarouch{at}bidmc.harvard.edu).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted July 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Dan H. Barouch, Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
medRxiv 2021.07.05.21259918; doi: https://doi.org/10.1101/2021.07.05.21259918
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Dan H. Barouch, Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, Jinyan Liu, Abishek Chandrashekar, Shivani Patel, Mathieu Le Gars, Anne Marit de Groot, Dirk Heerwegh, Frank Struyf, Macaya Douoguih, Johan van Hoof, Hanneke Schuitemaker
medRxiv 2021.07.05.21259918; doi: https://doi.org/10.1101/2021.07.05.21259918

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (323)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)